Todas as informações que poderiam relevar a identidade do paciente foram removidas para manter sua privacidade. Os fatos deste caso são baseados em casos médicos reais, mas o caso e as informações fornecidas são oferecidos apenas para fins educativos. As informações apresentadas não são oferecidas nem servem como consulta ou segunda opinião.
ATLAS de IHQ
Navegue pelas imagens de lâmina inteira (WSIs) na galeria de imagens de IHQ, que contém casos clínicos fornecidos e pontuados consensualmente pelo corpo docente de patologia. Para os casos clínicos apresentados, participe da pesquisa: Qual é a sua interpretação?
Members of the Breast Pathology Faculty have been contracted as paid advisors through Daiichi Sankyo and AstraZeneca, and have received compensation for their time.
EXPLORE CASOS CLÍNICOS
Galeria de imagens de Imuno-histoquímica
Explore os casos clínicos selecionados e organizados dentro de categorias. Clique em cada miniatura para ampliar a imagem e selecione Visualizar imagem de lâmina inteira para avaliar a WSI em detalhes.
- Padrões de coloração desafiadores
- Padrões/artefatos de coloração inespecíficos
- Casos clínicos sem pontuação aprovada consensualmente
- Padrões de coloração não desafiadores
PONTUAÇÃO
Qual é a sua interpretação?
Clique no carrossel de imagens, visualize todas as imagens de lâmina inteira e selecione sua pontuação de imuno-histoquímica. Envie para comparar a sua pontuação com a de outros ou simplesmente clique em “revelar pesquisa”.
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Dr. Michael Feldman
Vice Chair of Clinical Services, Pathology and Laboratory Medicine, Hospital of the University of PennsylvaniaInvasive breast carcinoma
Mobile View Text
HER2, human epidermal growth factor receptor 2; IHC, immunohistochemistry; IPLC, invasive pleomorphic lobular carcinoma; NST, non-special type; WSI, whole slide image.
Request an AstraZeneca Medical Affairs Representative Follow-Up